Vaxess lays out path to the clinic for its silk-derived, drug-dispersing patch
The Cambridge-based biotech has spent the last seven years developing a patch it hopes will disperse everything from vaccines to cancer treatments through roughly 120 microscopic needles made from silk proteins.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Vaccines | Health Management | Pharmaceuticals | Vaccines